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SURGERY FOR ACQUIRED
HEART DISEASE
EDITORIAL (CON) RE MINIMALLY INVASIVE PORT-ACCESS MITRAL VALVE SURGERY
John C. Baldwin, MD
The article titled “Minimally Invasive Port-AccessMitral Valve Surgery,” by Professor Mohr and
his colleagues in Leipzig (see page 567), reports an
interesting clinical experience in the context of the
current interest in “minimally invasive” cardiac sur-
gery by the business community, the public, and
many of us in the thoracic surgery profession.
Clearly, our profession is committed to performing
cardiac surgery with the least possible morbidity for
our patients. In this sense (and, by and large, in the
operative technical sense), the various minimalistic
approaches are not really new and certainly do not
represent the “genie out of the bottle” phenomenon
that is sometimes rather hyperbolically suggested.
Smaller incisions, gentle handling of tissue and
judicious use of retractors, avoidance of fracturing
ribs, minimizing cautery, smaller and fewer chest
tube sites, use of short-acting anesthetics and early
extubation protocols, more liberal use of regional
blocks, and even use of local anesthesia in combi-
nation with general and regional anesthesia are all
part of the rapidly changing picture in performing
cardiac surgery with less morbidity. Although the
authors of this article state that “the aim of the study
was to minimize surgical access,” surely our focus
should be on minimizing trauma rather than access.
Minimizing access implies maximizing technical dif-
ficulty. Moreover, as we have learned with thoraco-
scopic lung surgery, effective access to and exposure
of relevant anatomy can be even better with video-
assisted approaches in some kinds of operations.
The authors of this study should be commended
for their objective and candid report of the clinical
results. Bypass and crossclamp times, postoperative
intubation times, and intensive care unit and hospi-
tal stays were all relatively long in this early experi-
ence. Two serious and clinically evident aortic dis-
sections occurred, and both required emergency
resection of the aorta, with one patient dying in the
operating room. Three mitral valve repairs were
unsuccessful, and three of the 23 patients undergo-
ing valve replacement had perivalvular leaks and
required a second operation. Three patients re-
quired reexploration for bleeding. Mortality was
9.8%. When the authors compared these patients
retrospectively with other patients having mitral
valve operations at the same institution, they ob-
served no decrease in pain. The article states that
the aim of minimally invasive procedures is “reduc-
ing postoperative pain, recovery time, and cost,” and
the information in this article suggests that these
goals were not realized.
Although neurologic data are not presented in
this article, “the high incidence of postoperative
confusion” is mentioned, and we have seen numer-
ous reports of neurologic problems with this ap-
proach described on the Internet. This increased
incidence may be due to anatomically distorting
effects of the balloon in the arch, retained air, or
embolic phenomena. In any event, this is an impor-
tant consideration.
As the authors acknowledged, demonstration of
“feasibility” does not constitute a useful analysis of
the relative merits of this approach as compared
with standard cardiac procedures. Some have sug-
gested the importance of a “learning curve,” but it is
important to remember that the central features of
this approach are not new. Cardiopulmonary bypass,
arguably the salient cause of morbidity, is conserved.
Bypass is not new and not a factor in the learning
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curve. By the same token, cannulation of the femo-
ral artery and femoral vein are, for most cardiac
surgeons, very familiar techniques and not part of a
learning curve. Valve repair or replacement via
thoracotomy is also quite familiar to many practic-
ing cardiothoracic surgeons, not part of a learning
curve. Thus further experience with these tech-
niques is not likely to yield significant benefit.
The central hypothesis that needs to be tested is the
hypothesis that multiple port sites, insertion of pulmo-
nary artery vent and coronary sinus cannula by the
anesthesiologist, and femoral cannulation for cardio-
pulmonary bypass taken together are significantly less
morbid than median sternotomy. Parenthetically, the
use of terminology such as “endopulmonary event”
and “endoaortic clamp” obfuscates rather simple and
well-established technical concepts.
In this and other proposed approaches to “vid-
eo-assisted” thoracic surgery, the analogy with
laparoscopic cholecystectomy is usually raised.
With open cholecystectomy, the morbidity of the
operation was largely related to the incision. This,
of course, is not true for cardiac surgery. Avoid-
ance of morbidity of the muscle-splitting abdom-
inal incision in cholecystectomy was new. How-
ever, performance of incisions on the lateral chest
wall is not new. Ablative surgery (laparoscopic
cholecystectomy) via a surgical telescope was new
to most general surgeons in the early days of
laparoscopic cholecystectomy. Thoracoscopic sur-
gery is not new to most cardiothoracic surgeons.
Femoral-femoral bypass is well-established; car-
diopulmonary bypass is well-established; perfor-
mance of valvular surgery via thoracotomy is
well-established. Thus the suggestion that reser-
vations about this approach represent simple re-
sistance to change is probably unfounded.
The decision to perform the operations in this
report was reviewed by a local ethics committee, and
the patients were given the opportunity to sign a
written consent form. Although the article does not
include the specifics of this form, the informed
consent should include a clear explanation of the
fact that we do not know whether cardiac surgical
procedures can be performed in this way with the
same safety and outcomes that are expected with a
standard approach via median sternotomy. The con-
sent form should also state that we do not know yet
whether this approach will result in less pain and a
shorter hospital stay. Regrettably, patients are
sometimes told that this procedure is “FDA ap-
proved,” although the Food and Drug Administra-
tion has no jurisdiction over operations.
All of these considerations underscore the con-
tinuing compelling need for rigorous outcomes anal-
ysis in cardiac surgery. First, we need to continue to
analyze what factors actually constitute important
causes of morbidity. Technologies that hypotheti-
cally address these factors should then be evaluated.
Second, new technologies such as this one should be
studied in randomized prospective comparison with
conventional techniques. Otherwise, any assertions
about lesser morbidity or lesser cost will never be
proven. More important, we will never know
whether it is appropriate to offer these modalities to
our patients.
This approach may have important application in
selected patients. In general, we must maintain our
commitment to reduction of morbidity and mortal-
ity, to offering better value to our patients, and to
technical innovation (new devices, as well as funda-
mentally new strategies—e.g., transmyocardial
channel formation, gene and growth factor trans-
fer). These goals can be achieved only by dispassion-
ate examination of the data and by well-designed
prospective comparative studies.
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